Prestige Consumer Healthcare Inc
NYSE:PBH

Watchlist Manager
Prestige Consumer Healthcare Inc Logo
Prestige Consumer Healthcare Inc
NYSE:PBH
Watchlist
Price: 84.85 USD 0.84% Market Closed
Market Cap: 4.2B USD
Have any thoughts about
Prestige Consumer Healthcare Inc?
Write Note

Prestige Consumer Healthcare Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Prestige Consumer Healthcare Inc
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Prestige Consumer Healthcare Inc
NYSE:PBH
Cost of Revenue
-$497.5m
CAGR 3-Years
-5%
CAGR 5-Years
-4%
CAGR 10-Years
-6%
Johnson & Johnson
NYSE:JNJ
Cost of Revenue
-$27B
CAGR 3-Years
3%
CAGR 5-Years
0%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Cost of Revenue
-$11.4B
CAGR 3-Years
-6%
CAGR 5-Years
-10%
CAGR 10-Years
-11%
Pfizer Inc
NYSE:PFE
Cost of Revenue
-$17.5B
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
-6%
Merck & Co Inc
NYSE:MRK
Cost of Revenue
-$14.8B
CAGR 3-Years
-2%
CAGR 5-Years
-2%
CAGR 10-Years
2%
Eli Lilly and Co
NYSE:LLY
Cost of Revenue
-$7.8B
CAGR 3-Years
-4%
CAGR 5-Years
-11%
CAGR 10-Years
-4%
No Stocks Found

Prestige Consumer Healthcare Inc
Glance View

Market Cap
4.2B USD
Industry
Pharmaceuticals

Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. The company is headquartered in Tarrytown, New York and currently employs 505 full-time employees. The company went IPO on 2005-02-10. The firm operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its brands include BC/Goody's, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Fleet, Gaviscon, Luden's, Monistat, Nix, Summer's Eve, Fess and Hydralyte. Its subsidiaries include Blacksmith Brands, Inc., C.B. Fleet TopCo, LLC, C.B. Fleet HoldCo, LLC, C.B. Fleet, LLC, C.B. Fleet Company, Incorporated and C.B. Fleet Investment Corporation.

PBH Intrinsic Value
77.13 USD
Overvaluation 9%
Intrinsic Value
Price

See Also

What is Prestige Consumer Healthcare Inc's Cost of Revenue?
Cost of Revenue
-497.5m USD

Based on the financial report for Sep 30, 2024, Prestige Consumer Healthcare Inc's Cost of Revenue amounts to -497.5m USD.

What is Prestige Consumer Healthcare Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-6%

Over the last year, the Cost of Revenue growth was 2%. The average annual Cost of Revenue growth rates for Prestige Consumer Healthcare Inc have been -5% over the past three years , -4% over the past five years , and -6% over the past ten years .

Back to Top